ACTAZE

Found in: Australia

Active ingredients

UNII: X4OV71U42S - PIOGLITAZONE

Pioglitazone effects may be mediated by a reduction of insulin resistance. Pioglitazone appears to act via activation of specific nuclear receptors (peroxisome proliferator activated receptor gamma) leading to increased insulin sensitivity of liver, fat and skeletal muscle cells in animals. Treatment with pioglitazone has been shown to reduce hepatic glucose output and to increase peripheral glucose disposal in the case of insulin resistance.

Medicine classification

ATC Code
Title
Class
Pioglitazone
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BG Thiazolidinediones

Identifiers

Authority
Identifier(s)
Pharmaceutical Benefits Scheme (AU)
Identifier(s): 8694N, 8695P, 8696Q